Document is current
Any future updates will be listed below
-
Authors
Faria, André M.
Valerio, Cynthia M.
Barcellos, Cristiano R.
Oliveira, Ricardo A.
Trujilho, Fábio R.
Baiocchi, Jaqueline M. T.
Cifarelli, Vincenza
Scherer, Philipp E.
Halpern, Bruno
- License Information
-
More Information
Article History
Received: 6 June 2025
Accepted: 17 November 2025
First Online: 17 January 2026
Competing interests
: André M. Faria has declared no competing interests. Cynthia M. Valerio has served as a consultant for Eli-Lilly, Novo Nordisk, Merck, Boehringer Ingelheim, Chiesi and PTC. Cristiano R. Barcellos has served as a consultant for Novo Nordisk, Astra Zeneca, Merck, Eli-Lilly, Boehringer Ingelheim and Libbs. Ricardo A. Oliveira has served as a consultant for AstraZeneca, Besins, Boehringer Ingelheim, Eli-Lilly, Eurofarma, Merck, Novo Nordisk and Libbs. Jaqueline M. T. Baiocchi is a Coordinator at Instituto Lipedema Brasil, a private practice clinic located in São Paulo, Brazil. Fábio R. Trujilho has served as a consultant for Aché, AstraZeneca, BracePharma, Boehringer Ingelheim, Eli Lilly, EMS, Eurofarma, Johnson & Johnson, Myrallis, Merck, Novo Nordisk, Servier, Scitech Medical and Takeda. He is also the current president of the Latin American Obesity Federation (FLASO), President of the Brazilian Association for the Study of Obesity and Metabolic Syndrome (ABESO) and President of the Obesity Department of the Brazilian Society of Endocrinology and Metabolism (SBEM). Vincenza Cifarelli has declared no competing interests. Philipp E. Scherer has declared no competing interests. Bruno Halpern has served as a consultant for Novo Nordisk, Astra Zeneca, Merck, Eli-Lilly, Boehringer Ingelheim and Currax. He is also President-Elect of the World Obesity Federation.
